[Insert Authors]. Hypertriglyceridemia induced by continuous propofol infusion in obese patients with coronavirus disease 2019. Ann Pharmacother. In press.
2.
WitenkoCJLittlefieldAJAbedianSAnABariePSBergerK.The safety of continuous infusion propofol in mechanically ventilated adults with coronavirus disease 2019. Ann Pharmacother. Published online May 14, 2021. doi:10.1177/10600280211017315
3.
JohnsonALAltshulerDSchwartzDRPapadopoulosJ.Effect of obesity on propofol dosing requirements in mechanically ventilated patients in a medical intensive care unit. J Emerg Crit Care Med. 2018;2:97. doi:10.21037/jeccm.2018.11.01
4.
KappCMZaehSNiedermeyerSPunjabiNMSiddharthanTDamarlaM.The use of analgesia and sedation in mechanically ventilated patients with COVID-19 acute respiratory distress syndrome. Anesth Analg. 2020;131:e198-e200. doi:10.1213/ANE.0000000000005131
5.
HanidziarDBittnerEA.Sedation of mechanically ventilated COVID-19 patients: challenges and special considerations. Anesth Analg. 2020;131:e40-e41. doi:10.1213/ANE.0000000000004887
6.
BalakrishnaAWalshECHamidiA, et al. An examination of sedation requirements and practices for mechanically ventilated critically ill patients with COVID-19. Am J Health Syst Pharm. Published online May 16, 2021. doi:10.1093/ajhp/zxab202
7.
KenesMTMcSparronJIMarshallVDReniusKHyzyRC. Propofol-associated hypertriglyceridemia in coronavirus disease 2019 versus noncoronovirus disease 2019 acute respiratory distress syndrome. Crit Care Explor. 2020;2:e0303. doi:10.1097/CCE.0000000000000303 9
8.
DevlinJWLauAKTaniosMA. Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors. Pharmacotherapy. 2005;25:1348-1352. doi:10.1592/phco.2005.25.10.1348 10
9.
CorradoMJKovacevicMPDubeKMLupiKESzumitaPMDeGradoJR. The incidence of propofol-induced hypertriglyceridemia and identification of associated risk factors. Crit Care Explor. 2020;2:e0282. doi:10.1097/ CCE.0000000000000282
